Sizes Available: 6 Gram - 3/16 oz
Cagrilintide + retatrutide swaps semaglutide for retatrutide, which already hits three receptors (GLP-1, GIP, glucagon)
Administration and Safety TB-500 Administration: Commonly given via subcutaneous injection Typically used in 46 week cycles Initial phase: 23 injections per week Maintenance phase: Reduced frequency as directed by a healthcare provider BPC-157 Administration: Can be taken via subcutaneous injection, localized injection, or oral capsule (for gut health) Dosage varies depending on injury type and severity Can be used for short-term injury recovery or longer cycles for chronic conditions Safety Note: Both TB-500 and BPC-157 should be used under medical supervision
Co-authored by Carlotta Butler, RN, MPH This article was co-authored by Carlotta Butler, RN, MPH
Over time, our bodies produce fewer peptides, affecting everything from our skin and hair to our metabolism and energy levels